Zephyr Endobronchial Valve
Device Pulmonology
PDI 00811907030126
General payments
$3,242,169
Research payments
$1,192,917
Through program year 2025, $3,242,169 in general payments and $1,192,917 in research payments were reported against Zephyr Endobronchial Valve (Pulmonology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $966,295 | 5,514 |
| 2025 | Research | $84,339 | 35 |
| 2024 | General | $847,726 | 4,502 |
| 2024 | Research | $358,333 | 104 |
| 2023 | General | $639,271 | 3,789 |
| 2023 | Research | $475,304 | 108 |
| 2022 | General | $545,116 | 2,325 |
| 2022 | Research | $274,942 | 72 |
| 2021 | General | $243,763 | 1,276 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 75 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
17,406 general · 319 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.